Učitavanje...

Prognostic impact of six versus eight cycles of standard regimen in patients with diffuse large B-cell lymphoma: propensity score-matching analysis

BACKGROUND: R-CHOP-21 has been the standard treatment for diffuse large B-cell lymphoma (DLBCL), but there is a paucity of evidence focusing on the number of cycles of regimens. PATIENTS AND METHODS: We conducted a retrospective study to compare the effectiveness of six cycles of standard regimens v...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:ESMO Open
Glavni autori: Oiwa, K., Fujita, K., Lee, S., Morishita, T., Tsukasaki, H., Negoro, E., Hara, T., Tsurumi, H., Ueda, T., Yamauchi, T.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2021
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8287142/
https://ncbi.nlm.nih.gov/pubmed/34271313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2021.100210
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!